Close
CDMO Safety Testing 2026
Novotech

Biocair transports COVID-19 antibody tests for the German Football Association

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Transforming the Future of Pharmaceutical Innovation

The pharmaceutical industry stands at the edge of a...

eschbach Unveils Seqonis Intelligent Operations Platform

eschbach has renamed its flagship enterprise software platform, Shiftconnector,...

QIAGEN and NVIDIA Join Forces to Advance AI-Driven Drug Discovery

QIAGEN's Digital Insights bioinformatics division is set to integrate...
- Advertisement -

As part of the agreement, Biocair will transport selected blood samples to specialist laboratories for investigation to find out if the individual has developed antibodies against the SARS-CoV-2 virus.

The Bundesliga was the first European football league to restart amidst the ongoing pandemic. As a result, the league has implemented several protective measures to guard staff and players against COVID-19. This includes mandatory testing across all clubs.

Miguel Rodriguez, Client Relationship Manager at Biocair GmbH, comments:

“It is a great honour to be able to provide logistical support to the Deutscher Fußball-Bund’s efforts in providing COVID-19 antibody tests.

Throughout the pandemic Biocair has been part of numerous projects worldwide involving the transportation of COVID-19 related materials, including blood samples, antibodies and test kits to help support research and trials.

We should be proud of the small role we are playing in tackling COVID-19”.

Biocair is fully committed to delivering continuity of service within the life sciences supply chain throughout the pandemic. The company continues to design and implement new solutionsto ensure its customers’ critical shipments are transported both safely and effectively, despite the extremely challenging climate.

About Biocair
Biocair is a specialist courier with over 30 years of dedicated experience in the pharmaceutical, biotechnology and life science sectors. The company has built up a unique, client-centric approach by employing scientists in front-line logistics positions and assembling a team of best-in-class industry experts in quality, cold chain and regulatory compliance amongst others. Biocair focuses on providing the most comprehensive service options available whilst delivering flexible, tailored, cost effective logistics solutions to all clients.

Biocair operates across Europe, Africa, Asia and the Americas.

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast – stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector

Latest stories

Related stories

Transforming the Future of Pharmaceutical Innovation

The pharmaceutical industry stands at the edge of a...

eschbach Unveils Seqonis Intelligent Operations Platform

eschbach has renamed its flagship enterprise software platform, Shiftconnector,...

QIAGEN and NVIDIA Join Forces to Advance AI-Driven Drug Discovery

QIAGEN's Digital Insights bioinformatics division is set to integrate...

Bioprocess Analytics Improving Biologics Manufacturing

The immense complexity of modern biopharmaceutical production is being navigated through the strategic and systematic application of bioprocess analytics improving biologics manufacturing. By leveraging real-time data streams and advanced monitoring tools, manufacturers can gain a granular, molecular-level understanding of cellular behavior and the surrounding environmental conditions within the bioreactor. This proactive, data-driven approach allows for immediate, automated adjustments that optimize therapeutic yield, ensure absolute product consistency, and significantly streamline the arduous path toward commercial-scale production in a highly regulated global environment.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »